GSK: Architecting the AI-Ready Enterprise
GSK determined that reaching its goal of impacting 2.5 billion patients by 2030 required transformation beyond adopting new technology — establishing a data-centric mindset embedded in end-to-end processes without disrupting operations. GSK migrated to Veeva Vault CRM as an AI-ready foundation, complemented by Vault AI, PromoMats, MedComms, Development Cloud, and Quality Cloud, prioritizing rapid deployment with zero disruption. Per Kieron Scrutton, SVP, Enterprise Systems: "Moving to Vault CRM early was a strategic choice to secure an AI-ready foundation because while the technology is already here, true transformation requires the discipline to embed a data-centric mindset into every end-to-end process." No specific numerical results are disclosed.
Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Veeva Systems on its own site — read the original case study on veeva.com ↗
Related use cases
- 01Transforming Content Operations for 2x Faster Time to Market
- 02Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 03How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 04Reaching Underserved Communities with Smarter Targeting
- 05Building Agile Territory Strategies to Scale Pre-Commercial Field Teams
- 06How Alfasigma Unified Regulatory Data and Processes for Cross-Functional Alignment